Blood biomarkers for the prediction of outcome after cardiac arrest: an international prospective observational study within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial.
Moseby-Knappe M, Levin H, Ullén S, Zetterberg H, Blennow K, Lagebrant A, Dankiewicz J, Jakobsen JC, Lilja G, Nichol AD, Eastwood G, Ainscough K, Thomas MJC, Grejs AM, Keeble TR, Rylander C, Düring J, Wise MP, Hovdenes J, Storm C, Borgquist O, Cariou A, Deye N, Lascarrou JB, Bannard-Smith J, Undén J, Vignon P, Legriel S, Šmíd O, Pogson D, Karasek J, McGuigan PJ, Joannidis M, Kirkegaard H, Bewley J, Christensen S, Maccaroni MR, Valerianova A, Lundin A, Lybeck A, Leithner C, Varhaník F, Sweet K, Walden A, Friberg H, Cronberg T, Nielsen N; TTM2 biobank study investigators.
Moseby-Knappe M, et al.
Lancet Respir Med. 2025 Dec 11:S2213-2600(25)00363-7. doi: 10.1016/S2213-2600(25)00363-7. Online ahead of print.
Lancet Respir Med. 2025.
PMID: 41391459